The quarter cleared the near-term bar. Adjusted EPS of $0.56 exceeded the published consensus of roughly $0.53, while revenue of $6.26 billion was also ahead of the roughly $6.19 billion expectation. That makes this a real, if modest, operational beat—not a beat created by the large GAAP loss. (Financial Highlights; Schedule 7)
| Metric | Q2 2026 actual | Q2 2025 | Standing expectation / prior outlook |
|---|---|---|---|
| Net sales | $6.262B | $6.352B | Published consensus: ~$6.19B (Financial Highlights) |
| Organic net sales growth | (1.3)% | — | — (Schedule 2) |
| Adjusted EPS | $0.56 | $0.69 | Published consensus: ~$0.53 (Schedule 7) |
| Adjusted operating income | $1.041B | $1.276B | — (Schedule 4) |
| FY organic-sales outlook | (2.0)% to (0.5)% | — | Prior: (3.5)% to (1.5)% (Current and Prior Outlook) |
| FY adjusted-EPS outlook | $2.03–$2.09 | — | Prior: $1.98–$2.10 (Current and Prior Outlook) |
| Six-month free cash flow | $1.659B | $1.504B | FY conversion outlook raised to ~110% from ~100% (Schedule 16; Current and Prior Outlook) |
The guidance change is better on sales, but not a broad profit reset. The company lifted its organic-sales range by 150 basis points at both ends, signaling a less severe sales decline than it previously expected. But the adjusted-EPS range is only modestly improved at the low end and narrowed, while constant-currency adjusted operating-income guidance still calls for a steep 16%–18% decline. Management is also putting an additional $100 million into brand investment, bringing incremental spending to about $700 million. (Current and Prior Outlook)
The central weakness—falling volumes in the core business—remains. Companywide organic sales fell 1.3%, as 1.3 points of price gains did not offset a 2.6-point volume/mix decline. North America was the main drag: organic sales fell 2.7% and volume/mix dropped 3.8 points. Emerging Markets provided the offset, with 8.5% organic growth and positive volume/mix, but it is not yet large enough to counter softness in the largest segment. (Schedule 2)
Underlying profitability was weaker despite the beat. Adjusted operating income declined 18.4% and adjusted EPS fell 18.8% year over year, with higher advertising, manufacturing and logistics costs, and variable compensation outweighing pricing and efficiencies. The GAAP loss of $4.60 per share chiefly reflects $7.35 billion of impairment charges; those are non-cash and excluded from adjusted results, but they still represent a sizable reduction in the carrying value of goodwill and intangible assets. (Financial Highlights; Schedule 4; Schedule 7)
Cash flow is the cleanest support for the improved outlook, though working capital helped. Six-month free cash flow rose to $1.66 billion from $1.50 billion, and free-cash-flow conversion reached 123%. However, operating cash flow also benefited from higher accounts payable and other current liabilities, while inventory consumed cash, so the improvement was not solely the result of stronger underlying earnings. The company used cash to repay $2.98 billion of long-term debt while paying $949 million in dividends. (Schedule 15; Schedule 16)
Read the original 8-K on SEC EDGAR ↗